CCNE1 amplification or cyclin E1 overexpression has also been described in a number of other cancers including osteosarcoma (Lockwood et al., 2011), breast (Karakas et al., 2016), and non-small-cell lung cancer (Freemantle and Dmitrovsky, 2010). Here, CCNE1 is linked to osteosarcoma.